osteoarthritis
Topical pain management for musculoskeletal conditions
There is good evidence for the use of topical preparations to manage inflammation and pain in musculoskeletal conditions including soft tissue injuries; localised soft tissue rheumatism and localised forms of …
Osteoarthritis: management and emerging therapies
Management of osteoarthritis continues to evolve. Emerging therapies contribute to the growing body of evidence that informs treatment and management. To provide evidence-informed advice and education, pharmacists need to be …
Research Roundup
Debbie Rigby rounds up the latest in research news Approach to schizophrenia Schizophrenia is the most common of a group of psychotic disorders that occur in approximately 3% of the …
Research Roundup
Debbie Rigby takes a look at the latest in research news Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN) For patients with heart …
Arthritis: raising awareness and managing myths
The number of Australians living with arthritis continues to grow, while medication myths and knowledge gaps can delay diagnosis and hinder treatment One in seven Australians live with arthritis. This …
Musculoskeletal health: Supportive shoes reduces knee pain in severe OA
Wearing stable, supportive footwear reduces knee pain significantly in patients with severe knee osteoarthritis, according to results of a randomised, controlled trial1 presented at the OARSI 2021 World Congress. Clinical …
Research Roundup
Debbie Rigby rounds up the latest in research news Regular use of proton pump inhibitors and risk of type 2 diabetes A prospective analysis over 200,000 participants shows an association …
Professor Andrew McLachlan presents the recent trends and gaps identified in OA pain management
In this video, Professor Andrew McLachlan discusses how a patient’s health literacy can impact their choice of self-management strategies for OA symptoms and how a lack of condition awareness can …
Professor Andrew McLachlan explains how pharmacists play a critical role in identifying and supporting patients with Osteoarthritis
A recent study found only 3.5% of participants with self-reported OA symptoms sought advice from a pharmacist despite the critical role pharmacists play in helping patients on their pain management …
APP2021: Professor David Hunter on how pharmacists can facilitate more positive OA management outcomes
Osteoarthritis (OA) is a leading cause of disability that affects more than 3 million Australians. At APP 2021, Professor David Hunter, Florance and Cope Chair of Rheumatology, Professor of Medicine, the University of Sydney spoke …
Research Roundup
Debbie Rigby takes a look at the latest in research news Risk Versus Benefit of Combined Aspirin and Warfarin Therapy in Patients With Atrial Fibrillation In this retrospective, cohort study …
Research Roundup
Debbie Rigby rounds up the latest in research news Amiodarone in the aged Amiodarone is a highly effective antiarrhythmic drug, but can have serious adverse effects, particularly in older patients. …